Agenus receives termination notice from Incyte for LAG-3/TIM-3 license; rights revert to Agenus

AGENUS INC

Incyte terminates License Agreement effective Feb 4, 2026; all rights to LAG-3 and TIM-3 revert to Agenus.
Incyte previously terminated OX40 (Oct 2023) and GITR/undisclosed (May 2024) programs.
Agenus will evaluate future opportunities, including internal development or new partnerships.
Termination follows Incyte's July 2024 announcement to discontinue LAG-3 and TIM-3 development.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.